Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The relation between viremia and clinical outcome in individuals infected with human immunodeficiency virus-type 1 (HIV-1) has important implications for therapeutic research and clinical care. HIV-1 RNA in plasma was quantified with a branched-DNA signal amplification assay as a measure of viral load in a cohort of 180 seropositive men studied for more than 10 years. The risk of acquired immunodeficiency syndrome (AIDS) and death in study subjects, including those with normal numbers of CD4 + T cells, was directly related to plasma viral load at study entry. Plasma viral load was a better predictor of progression to AIDS and death than was the number of CD4 + T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
KASLOW, R. A., OSTROW, D. G., DETELS, R., PHAIR, J. P., POLK, B. F., RINALDO, C. R., & STUDY, F. T. M. A. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.310 · Cited by 1,194
Self-citationQuantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
Ho, D. D., Moudgil, T., & Alam, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212401 · Cited by 1,064
Fahey, J. L., Taylor, J. M. G., Detels, R., Hofmann, B., Melmed, R., Nishanian, P., & Giorgi, J. V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220305 · Cited by 1,023
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., & Gupta, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00003 · Cited by 917
Self-citation
Cited by
Items 101–139 of 139
HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease Outcome
Soghoian, D. Z., Jessen, H., Flanders, M., Sierra-Davidson, K., Cutler, S., Pertel, T., Ranasinghe, S., Lindqvist, M., Davis, I., Lane, K., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003165 · Cited by 279
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
Rey-Cuillé, M.-A., Berthier, J.-L., Bomsel-Demontoy, M.-C., Chaduc, Y., Montagnier, L., Hovanessian, A. G., & Chakrabarti, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3872-3886.1998 · Cited by 279
Okoye, A., Meier-Schellersheim, M., Brenchley, J. M., Hagen, S. I., Walker, J. M., Rohankhedkar, M., Lum, R., Edgar, J. B., Planer, S. L., Legasse, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070567 · Cited by 279
Current status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Aupeix, K., Hugel, B., Martin, T., Bischoff, P., Lill, H., Pasquali, J. L., & Freyssinet, J. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119317 · Cited by 274
Pantaleo, G., Demarest, J. F., Schacker, T., Vaccarezza, M., Cohen, O. J., Daucher, M., Graziosi, C., Schnittman, S. S., Quinn, T. C., Shaw, G. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.254 · Cited by 273
Risky Business: The Market for Unprotected Commercial Sex
Gertler, P., Shah, M., & Bertozzi, S. M. (2005) · Journal of Political Economy · doi:10.1086/429700 · Cited by 268
Viral Dynamics in HIV-1 Infection
Finzi, D., & Siliciano, R. F. (1998) · Cell · doi:10.1016/s0092-8674(00)81427-0 · Cited by 266
Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses
VandeWoude, S., & Apetrei, C. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-06 · Cited by 263
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
O'Brien, W. A., Hartigan, P. M., Daar, E. S., Simberkoff, M. S., & Hamilton, J. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00002 · Cited by 259
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
Hoffman, I. F., Jere, C. S., Taylor, T. E., Munthali, P., Dyer, J. R., Wirima, J. J., Rogerson, S. J., Kumwenda, N., Eron, J. J., Fiscus, S. A., et al. (1999) · Aids · doi:10.1097/00002030-199903110-00007 · Cited by 259
An HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257
Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.181 · Cited by 255
Distribution of Brain HIV Load in AIDS
Wiley, C. A., Soontornniyomkij, V., Radhakrishnan, L., Masliah, E., Mellors, J., Hermann, S. A., Dailey, P., & Achim, C. L. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00153.x · Cited by 253
Self-citationModeling HIV persistence, the latent reservoir, and viral blips
Rong, L., & Perelson, A. S. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.06.011 · Cited by 245
“Since viral replication is directly linked to CD4þ T cell depletion, viral evolution and disease progression (Mellors et al., 1996), the viral decline in the presence of combination therapy has profound clinical significance.”
BackgroundOrtiz, G. M., Nixon, D. F., Trkola, A., Binley, J., Jin, X., Bonhoeffer, S., Kuebler, P. J., Donahoe, S. M., Demoitie, M.-A., Kakimoto, W. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7371 · Cited by 237
Quiñones-Mateu, M. E., Ball, S. C., Marozsan, A. J., Torre, V. S., Albright, J. L., Vanham, G., van der Groen, G., Colebunders, R. L., & Arts, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9222-9233.2000 · Cited by 234
Cole, S. W., Korin, Y. D., Fahey, J. L., & Zack, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.610 · Cited by 228
“Basic viral replication rates play a critical role in driving HIV pathogenesis and long-term disease progression (70).”
BackgroundLifson, J. D., Nowak, M. A., Goldstein, S., Rossio, J. L., Kinter, A., Vasquez, G., Wiltrout, T. A., Brown, C., Schneider, D., Wahl, L., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9508-9514.1997 · Cited by 228
“This is noteworthy since the set point level is highly predictive of subsequent clinical course and outcome in both SIV-infected macaques and HIV-1-infected humans (24, 32, 33, 39, 56, 59).”
MethodFrequent Simian Foamy Virus Infection in Persons Occupationally Exposed to Nonhuman Primates
Switzer, W. M., Bhullar, V., Shanmugam, V., Cong, M.-E., Parekh, B., Lerche, N. W., Yee, J. L., Ely, J. J., Boneva, R., Chapman, L. E., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2780-2789.2004 · Cited by 220
“SFVCPZ may also be more transmissible because of higher viral loads in SFV-infected chimpanzees, since high viral loads are known to increase the transmission of other retroviruses (7, 22, 24).”
BackgroundForthal, D. N., Landucci, G., & Daar, E. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6953-6961.2001 · Cited by 220
“The level of viremia eventually attained represents a set point that correlates well with subsequent immunological and clinical events and is an important factor in the decision to institute antiretroviral therapy (22, 35).”
BackgroundGoujard, C., Bonarek, M., Meyer, L., Bonnet, F., Chaix, M.-L., Deveau, C., Sinet, M., Galimand, J., Delfraissy, J.-F., Venet, A., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/500213 · Cited by 216
“Long-lasting and intense symptoms during primary HIV infection are associated with poorer subsequent outcomes, but unlike during the chronic phase of infection, it is less established whether virological and/or immunological factors during primary HIV infection are predictive of disease progression [22–24].”
BackgroundUnderstanding the benign nature of SIV infection in natural hosts
Silvestri, G., Paiardini, M., Pandrea, I., Lederman, M. M., & Sodora, D. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33034 · Cited by 215
Oxenius, A., Price, D. A., Günthard, H. F., Dawson, S. J., Fagard, C., Perrin, L., Fischer, M., Weber, R., Plana, M., García, F., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202372199 · Cited by 212
Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways
Roeth, J. F., & Collins, K. L. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-05 · Cited by 193
Impact of opportunistic disease on survival in patients with HIV infection
Chaisson, R. E., Gallant, J. E., Keruly, J. C., & Moore, R. D. (1998) · AIDS · doi:10.1097/00002030-199801000-00004 · Cited by 189
“[10,11], CD4 cell levels also remain an important”
BackgroundVella, S., Schwartländer, B., Sow, S. P., Eholie, S. P., & Murphy, R. L. (2012) · AIDS · doi:10.1097/qad.0b013e32835521a3 · Cited by 181
“The result was a consequence of not only the availability of new drugs from different classes but also of: the understanding that HIV infection, even during the clinically latent phases of the disease, is characterized by an important viral turnover with continuous high-level virus replication [25–28]; the demonstrati…”
BackgroundPawelek, K. A., Liu, S., Pahlevani, F., & Rong, L. (2012) · Mathematical Biosciences · doi:10.1016/j.mbs.2011.11.002 · Cited by 166
“The viral set point has been shown to be predictive for the pace of disease development [34].”
BackgroundHel, Z., Stringer, E., & Mestecky, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0018 · Cited by 166
“predictive of HIV-1 disease progression (30), Lavreys et al.”
Backgroundde Wolf, F., Spijkerman, I., Schellekens, P. T., Langendam, M., Kuiken, C., Bakker, M., Roos, M., Coutinho, R., Miedema, F., & Goudsmit, J. (1997) · AIDS · doi:10.1097/00002030-199715000-00003 · Cited by 164
“In a longitudinal study of 180 seroprevalent individuals, the predictive value of HIV-1 RNA levels appeared to be independent of the predictive value of CD4+ T-cell counts [25].”
BackgroundResultIgarashi, T., Brown, C., Azadegan, A., Haigwood, N., Dimitrov, D., Martin, M. A., & Shibata, R. (1999) · Nature Medicine · doi:10.1038/5576 · Cited by 164
Chung, M. H., Richardson, B. A., Tapia, K., Benki-Nugent, S., Kiarie, J. N., Simoni, J. M., Overbaugh, J., Attwa, M., & John-Stewart, G. C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000422 · Cited by 109
“. Similarly, use of the alarm device was measured by self-report and was not able to be verified. It is possible that continuous use of the alarm device was overestimated and that the insignificant associations found in this study may have been due to poor participant participation in this intervention. The adherence…”
Kinetics of Virus-Specific CD8+T Cells and the Control of Human Immunodeficiency Virus Infection
Davenport, M. P., Ribeiro, R. M., & Perelson, A. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10096-10103.2004 · Cited by 101
“The long-term outcome of low-level chronic infection is unclear, but vaccinated monkeys had significantly increased survival compared to unvaccinated controls, and human studies suggest that lower HIV viral loads are associated with increased survival (35).”
ResultDistinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections
Armitage, A. E., Stacey, A. R., Giannoulatou, E., Marshall, E., Sturges, P., Chatha, K., Smith, N. M. G., Huang, X., Xu, X., Pasricha, S.-R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402351111 · Cited by 101
Saad, J. S., Ablan, S. D., Ghanam, R. H., Kim, A., Andrews, K., Nagashima, K., Soheilian, F., Freed, E. O., & Summers, M. F. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.027 · Cited by 95
“Soluble PI(4,5)P2 analogs containing truncated acyl chains bind HIV-2 MA and induce minor long-range structural changes but do not trigger myristate exposure.”
BackgroundInfluentialPromoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
Suzuki, K., Hattori, S., Marks, K., Ahlenstiel, C., Maeda, Y., Ishida, T., Millington, M., Boyd, M., Symonds, G., Cooper, D. A., et al. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.64 · Cited by 61
Mori, L. P., Corley, M. J., McAuley, A. T., Pang, A., Venables, T., Ndhlovu, L. C., Pipkin, M. E., & Valente, S. T. (2024) · Life Science Alliance · doi:10.26508/lsa.202402653 · Cited by 4
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection
Delanghe, J. R., Langlois, M. R., Boelaert, J. R., Van Acker, J., Van Wanzeele, F., van der Groen, G., Hemmer, R., Verhofstede, C., De Buyzere, M., De Bacquer, D., et al. (1998) · AIDS · doi:10.1097/00002030-199809000-00010 · Cited by 3
Metadata
- Authors
- Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A.
- Venue
- Science
- Published
- 1996-05-24
- Volume
- 272
- Issue
- 5265
- Pages
- 1167-1170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2012139740
- Cited by
- 2,660
- References
- 17
- FWCI
- 66.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.